“Molecular docking studies FDA approved Quercetin inhibitory potential of ATP synthase F0F1 subunit beta from Streptococcus mutans”, Multidisciplinary, Scientific Work and Management Journal, vol. 36, no. 2, pp. 1394–1397, May 2026, doi: 10.7492/xadsj448.